05.05.2021 22:10:39

Rigel Pharmaceuticals Inc. Bottom Line Rises In Q1

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) revealed a profit for its first quarter that rose from the same period last year.

The company's earnings totaled $39.50 million, or $0.22 per share. This compares with $21.24 million, or $0.13 per share, in last year's first quarter.

Analysts had expected the company to earn $0.00 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 45.3% to $81.02 million from $55.76 million last year.

Rigel Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $39.50 Mln. vs. $21.24 Mln. last year. -EPS (Q1): $0.22 vs. $0.13 last year. -Analysts Estimate: $0.00 -Revenue (Q1): $81.02 Mln vs. $55.76 Mln last year.

Nachrichten zu Rigel Pharmaceuticals IncShsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Rigel Pharmaceuticals IncShsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!